Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis

The induction of an effective immune response is critical for the success of mRNA-based therapeutics. Here, we developed a nanoadjuvant system compromised of Quil-A and DOTAP (dioleoyl 3 trimethylammonium propane), hence named QTAP, for the efficient delivery of mRNA vaccine constructs into cells. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Touray, Bubacarr J.B., Hanafy, Mostafa, Phanse, Yashdeep, Hildebrand, Rachel, Talaat, Adel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286238/
https://www.ncbi.nlm.nih.gov/pubmed/37359562
http://dx.doi.org/10.3389/fimmu.2023.1188754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286238/
https://www.ncbi.nlm.nih.gov/pubmed/37359562
http://dx.doi.org/10.3389/fimmu.2023.1188754

Ejemplares similares